Federica Rizzo

1.7k total citations
31 papers, 1.3k citations indexed

About

Federica Rizzo is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Federica Rizzo has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Genetics and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Federica Rizzo's work include Neurogenetic and Muscular Disorders Research (15 papers), Hereditary Neurological Disorders (11 papers) and Amyotrophic Lateral Sclerosis Research (10 papers). Federica Rizzo is often cited by papers focused on Neurogenetic and Muscular Disorders Research (15 papers), Hereditary Neurological Disorders (11 papers) and Amyotrophic Lateral Sclerosis Research (10 papers). Federica Rizzo collaborates with scholars based in Italy, Sweden and United States. Federica Rizzo's co-authors include Stefania Corti, Giacomo P. Comi, Nereo Bresolin, Monica Nizzardo, Sabrina Salani, Chiara Simone, Giulietta Riboldi, Chiara Donadoni, Elena Abati and Dario Ronchi and has published in prestigious journals such as Brain, Neurology and Scientific Reports.

In The Last Decade

Federica Rizzo

29 papers receiving 1.3k citations

Peers

Federica Rizzo

GENET

CMN

NEURO

Giulietta Riboldi Italy

Tali Ben‐Zur Israel

Irene Faravelli Italy

Ritchie Ho United States

Martina Maisel Germany

Martina Nardini Italy

Virginia B. Mattis United States

Lidia De Filippis Italy

Morwena Latouche France

Chien‐Ping Ko United States

Giulietta Riboldi Italy

Federica Rizzo

846 ×0.9

393 ×1.0

GENET

353 ×0.9

CMN

432 ×1.7

NEURO

170 ×0.8

Citations per year, relative to Federica Rizzo Federica Rizzo (= 1×) peers Giulietta Riboldi

Countries citing papers authored by Federica Rizzo

Since Specialization

Citations

This map shows the geographic impact of Federica Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Rizzo more than expected).

Fields of papers citing papers by Federica Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Rizzo. The network helps show where Federica Rizzo may publish in the future.

Co-authorship network of co-authors of Federica Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Rizzo. A scholar is included among the top collaborators of Federica Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Rizzo. Federica Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizzuti, Mafalda, M. D’Agostino, Linda Ottoboni, et al.. (2025). Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models. Stem Cell Reports. 20(12). 102711–102711.

Abati, Elena, Delia Gagliardi, Arianna Manini, et al.. (2024). Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort. Brain Communications. 6(5). fcae312–fcae312. 1 indexed citations

Rizzo, Federica, et al.. (2024). Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives. Neurobiology of Disease. 193. 106467–106467. 16 indexed citations

Abati, Elena, Mafalda Rizzuti, Alessia Anastasia, et al.. (2024). Charcot–Marie‐Tooth type 2A in vivo models: Current updates. Journal of Cellular and Molecular Medicine. 28(9). e18293–e18293. 5 indexed citations

Gagliardi, Delia, Megi Meneri, Valentina Melzi, et al.. (2022). Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets. Biomedicines. 10(3). 711–711. 17 indexed citations

Abati, Elena, Arianna Manini, Daniele Velardo, et al.. (2022). Clinical and genetic features of a cohort of patients with MFN2-related neuropathy. Scientific Reports. 12(1). 6181–6181. 18 indexed citations

Nizzardo, Monica, Michela Taiana, Federica Rizzo, et al.. (2020). Synaptotagmin 13 is neuroprotective across motor neuron diseases. Acta Neuropathologica. 139(5). 837–853. 34 indexed citations

Gioia, Roberta, Federica Rizzo, Elena Abati, et al.. (2020). Neural Stem Cell Transplantation for Neurodegenerative Diseases. International Journal of Molecular Sciences. 21(9). 3103–3103. 177 indexed citations

Gioia, Roberta, Elena Abati, Monica Nizzardo, et al.. (2020). Animal Models of CMT2A: State-of-art and Therapeutic Implications. Molecular Neurobiology. 57(12). 5121–5129. 6 indexed citations

10.

Rizzo, Federica, Sabrina Salani, Andreina Bordoni, et al.. (2019). RNAi/gene therapy combined approach as therapeutic strategy for Charcot-Marie-Tooth 2A (S58.005). Neurology. 92(15_supplement). 1 indexed citations

11.

Abati, Elena, et al.. (2019). Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art. Molecular Neurobiology. 56(9). 6460–6471. 21 indexed citations

12.

Romano, Giulia, Raffaella Klima, Federica Grilli, et al.. (2018). Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. Scientific Reports. 8(1). 1809–1809. 12 indexed citations

13.

Rizzo, Federica, Dario Ronchi, Sabrina Salani, et al.. (2016). Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons. Human Molecular Genetics. 25(19). 4266–4281. 50 indexed citations

14.

Nizzardo, Monica, C. Simoné, Federica Rizzo, et al.. (2016). Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype. Scientific Reports. 6(1). 21301–21301. 25 indexed citations

15.

Rizzo, Federica, Giulietta Riboldi, Roberto Del Bo, et al.. (2015). MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives. Journal of the Neurological Sciences. 356(1-2). 7–18. 100 indexed citations

16.

Nizzardo, Monica, Chiara Simone, Sabrina Salani, et al.. (2015). Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches. Scientific Reports. 5(1). 11746–11746. 38 indexed citations

17.

Simone, Chiara, Monica Nizzardo, Federica Rizzo, et al.. (2014). iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1. Stem Cell Reports. 3(2). 297–311. 32 indexed citations

18.

Nizzardo, Monica, Chiara Simone, Sabrina Salani, et al.. (2014). Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype. Clinical Therapeutics. 36(3). 340–356.e5. 44 indexed citations

19.

Nizzardo, Monica, Chiara Simone, Marianna Falcone, et al.. (2011). Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis. Cellular and Molecular Life Sciences. 69(10). 1641–1650. 16 indexed citations

20.

Salani, Sabrina, Chiara Donadoni, Federica Rizzo, et al.. (2011). Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. Journal of Cellular and Molecular Medicine. 16(7). 1353–1364. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact